Page 12 - 40163_Cardiology Overview Brochure modi 181217 copy
P. 12
Cardiology Experience : Unmatched Expertise
Over 45,000 Panels Analyzed Across Clinical Indications
Reason for referral: Inherited Cardiomyopathies
16%
HCM
11% DCM
54%
19% ARVC
Other Mixed
Cardiomyopathies
Cardiomyopathies
Marfan/TAAD/
Connective
Tissue
Disorders Reason for referral: Inherited Arrhythmias
Arrhythmias
1%
14% LQTS
8% Brugada Syndrome
CPVT
14% 63% SQTS
Mixed Arrhythmias
Distinguished History with Cardiology Next-Generation Sequencing Panels
• 1st company to leverage Next-Generation Sequencing in genetic testing for cardiac conditions
• 9+ years offering panel-based cardiac genetic testing
• Comprehensive testing menu to meet testing needs across clinical indications
2008: HCM and 2010: SQTS Panel 2012: SCA Arrhythmia, 2015: Combined Cardiac 2017:
Noonan Syndrome Launched Marfan/TAAD and Panel Launched Customizable
Panels Launched Prenatal Noonan Cardiology Panels
Panels Launched Launched
2009: DCM, LQTS, 2011: Marfan/Loeys- 2013: Comprehensive 2016: FH and
CPVT, BrS and ARVC Dietz Panel Launched Arrhythmia, Comprehensive HDCT Panels
Panels Launched Cardiomyopathy, HHT and Launched
PAH Panels Launched
11

